Cue Biopharma (CUE) financials · rev $27.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cue Biopharma (CUE) rev $27.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $27.5M | $9.29M |
| Operating Income | -$26.6M | -$41.5M |
| Net Income | -$26.6M | -$40.7M |
| EPS (Diluted) | -$0.28 | -$0.72 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $42.2M | $32.2M |
| Current Assets | $37.0M | $25.1M |
| Cash & Equivalents | $27.1M | $22.5M |
| PP&E | $241.0K | $471.0K |
| Total Liabilities | $15.8M | $14.7M |
| Current Liabilities | $13.5M | $13.7M |
| Short-term Debt | N/A | $37.0K |
| Long-term Debt | N/A | N/A |
| Total Debt | N/A | $37.0K† |
| Shareholders' Equity | $26.4M | $17.5M |
| Retained Earnings | -$368.5M | -$341.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$21.7M | -$36.3M |
| CapEx | $177.0K | $66.0K |
| Investing Cash Flow | $75.0K | $32.0K |
| Financing Cash Flow | $26.3M | $10.2M |
| Net Change in Cash | $4.68M | -$26.1M |
| Free Cash Flow | -$21.9M | -$36.4M |
FAQ
What is CUE P/E and revenue?
Cue Biopharma (CUE) rev $27.5M.
What is CUE revenue?
Cue Biopharma last cached revenue is $27.5M (FY2025).
Is CUE profitable?
Cue Biopharma last cached net income is -$26.6M (FY2025).
What are CUE total assets?
Cue Biopharma last cached total assets are $42.2M (FY2025).
What is CUE free cash flow?
Cue Biopharma last cached free cash flow is -$21.9M (FY2025).
Not investment advice. Cached statements, not a live tape.